Table 1.
The association of clinicopathological features in TCGA cohort.
| Characteristics | TCGA-LUAD cohort | ||
|---|---|---|---|
| High risk (%) | Low risk (%) | P value | |
| Age | |||
| ≤65 year | 131 (53.7%) | 112 (45.7%) | 0.0778 |
| >65 year | 113 (46.3%) | 133 (54.3%) | |
| Gender (%) | |||
| Female | 119 (48.8%) | 143 (58.4%) | 0.0334 |
| Male | 125 (51.2%) | 102 (41.6%) | |
| Pathologic stage | |||
| Ⅰ | 111 (45.5%) | 161 (65.7%) | <0.0001 |
| Ⅱ | 71 (29.1%) | 46 (18.8%) | |
| Ⅲ | 47 (19.3%) | 28 (11.4%) | |
| Ⅳ | 15 (6.1%) | 10 (4.1%) | |
| T stage | 0.0002 | ||
| T1 | 61 (25.0%) | 107 (43.7%) | |
| T2 | 143 (58.6%) | 114 (46.5%) | |
| T3 | 31 (12.7%) | 14 (5.7%) | |
| T4 | 8 (3.3%) | 8 (3.3%) | |
| TX | 1 (0.4%) | 2 (0.8%) | |
| N stage | 0.0015 | ||
| N0 | 143 (58.6%) | 180 (73.5%) | |
| N1 | 56 (23.0%) | 33 (13.5%) | |
| N2 | 41 (16.8%) | 23 (9.4%) | |
| N3 | 1 (0.4%) | 1 (0.4%) | |
| Nx | 3 (1.2%) | 8 (3.3%) | |
| M stage | 0.4295 | ||
| M0 | 162 (66.4%) | 164 (66.9%) | |
| M1 | 15 (6.1%) | 9 (3.7%) | |
| Mx | 67 (27.5%) | 72 (29.4%) | |